标题
Augmenting Antitumor Immune Responses with Epigenetic Modifying Agents
作者
关键词
-
出版物
Frontiers in Immunology
Volume 6, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2015-02-04
DOI
10.3389/fimmu.2015.00029
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Phase I/II Study of Azacitidine, Docetaxel, and Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Therapy
- (2015) Rakesh Singal et al. Clinical Genitourinary Cancer
- Expression of Cancer/Testis Antigens is Correlated with Improved Survival in Glioblastoma
- (2015) Marcelo R.P. Freitas et al. Oncotarget
- Alterations of immune response of non-small cell lung cancer with Azacytidine
- (2015) John Wrangle et al. Oncotarget
- Anti-neoplastic properties of hydralazine in prostate cancer
- (2015) Inês Graça et al. Oncotarget
- Immune regulation by low doses of the DNA methyltransferase inhibitor 5-azacitidine in common human epithelial cancers
- (2015) Huili Li et al. Oncotarget
- Demethylation of the miR-146a promoter by 5-Aza-2’-deoxycytidine correlates with delayed progression of castration-resistant prostate cancer
- (2014) Xiaolu Wang et al. BMC CANCER
- Treatment of resistant metastatic melanoma using sequential epigenetic therapy (decitabine and panobinostat) combined with chemotherapy (temozolomide)
- (2014) Chang Xia et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti-PD-1 Therapy
- (2014) J. M. Taube et al. CLINICAL CANCER RESEARCH
- SGI-110 and entinostat therapy reduces lung tumor burden and reprograms the epigenome
- (2014) Carmen S. Tellez et al. INTERNATIONAL JOURNAL OF CANCER
- Histone Acetylation Facilitates Rapid and Robust Memory CD8 T Cell Response through Differential Expression of Effector Molecules (Eomesodermin and Its Targets: Perforin and Granzyme B)
- (2014) Y. Araki et al. JOURNAL OF IMMUNOLOGY
- Epigenetic Regulation of Foxp3 Expression in Regulatory T Cells by DNA Methylation
- (2014) G. Lal et al. JOURNAL OF IMMUNOLOGY
- Development of a T Cell Receptor Targeting an HLA-A*0201 Restricted Epitope from the Cancer-Testis Antigen SSX2 for Adoptive Immunotherapy of Cancer
- (2014) Daniel Abate-Daga et al. PLoS One
- Novel Epigenetic Target Therapy for Prostate Cancer: A Preclinical Study
- (2014) Ilaria Naldi et al. PLoS One
- Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells
- (2014) K. Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The anticancer effects of HDAC inhibitors require the immune system
- (2014) Alison C West et al. OncoImmunology
- The histone deacetylase inhibitor, LBH589, promotes the systemic cytokine and effector responses of adoptively transferred CD8+ T cells
- (2014) Dominique N Lisiero et al. Journal for ImmunoTherapy of Cancer
- Cause and Consequence of Cancer/Testis Antigen Activation in Cancer
- (2013) Angelique W. Whitehurst Annual Review of Pharmacology and Toxicology
- Suberoylanilide hydroxamic acid (SAHA) causes tumor growth slowdown and triggers autophagy in glioblastoma stem cells
- (2013) Ming-Tsang Chiao et al. Autophagy
- Aerosolised 5-azacytidine suppresses tumour growth and reprogrammes the epigenome in an orthotopic lung cancer model
- (2013) M D Reed et al. BRITISH JOURNAL OF CANCER
- An Intact Immune System Is Required for the Anticancer Activities of Histone Deacetylase Inhibitors
- (2013) A. C. West et al. CANCER RESEARCH
- Analysis of the genomic response of human prostate cancer cells to histone deacetylase inhibitors
- (2013) Madeleine SQ Kortenhorst et al. Epigenetics
- A Novel Sirtuin 2 (SIRT2) Inhibitor with p53-dependent Pro-apoptotic Activity in Non-small Cell Lung Cancer
- (2013) Gesine Hoffmann et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cancer Regression and Neurological Toxicity Following Anti-MAGE-A3 TCR Gene Therapy
- (2013) Richard A. Morgan et al. JOURNAL OF IMMUNOTHERAPY
- MHC Class I Antigen Processing and Presenting Machinery: Organization, Function, and Defects in Tumor Cells
- (2013) P. Leone et al. JNCI-Journal of the National Cancer Institute
- Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents
- (2013) H Yang et al. LEUKEMIA
- The antimelanoma activity of the histone deacetylase inhibitor panobinostat (LBH589) is mediated by direct tumor cytotoxicity and increased tumor immunogenicity
- (2013) David M. Woods et al. MELANOMA RESEARCH
- Tenovin-D3, a Novel Small-Molecule Inhibitor of Sirtuin SirT2, Increases p21 (CDKN1A) Expression in a p53-Independent Manner
- (2013) A. R. McCarthy et al. MOLECULAR CANCER THERAPEUTICS
- Decitabine has a biphasic effect on natural killer cell viability, phenotype, and function under proliferative conditions
- (2013) Lisa M. Kopp et al. MOLECULAR IMMUNOLOGY
- Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group
- (2013) Mercedes Lobera et al. Nature Chemical Biology
- Effect of histone deacetylase and DNA methyltransferase inhibitors on the expression of the androgen receptor gene in androgen-independent prostate cancer cell lines
- (2013) BARBORA FIALOVA et al. ONCOLOGY REPORTS
- Low Dose Decitabine Treatment Induces CD80 Expression in Cancer Cells and Stimulates Tumor Specific Cytotoxic T Lymphocyte Responses
- (2013) Li-Xin Wang et al. PLoS One
- Inhibition of Histone Deacetylase 3 Causes Replication Stress in Cutaneous T Cell Lymphoma
- (2013) Christina E. Wells et al. PLoS One
- The Anti-Tumor Effects and Molecular Mechanisms of Suberoylanilide Hydroxamic Acid (SAHA) on the Aggressive Phenotypes of Ovarian Carcinoma Cells
- (2013) Shuo Chen et al. PLoS One
- Targeting CD28, CTLA-4 and PD-L1 Costimulation Differentially Controls Immune Synapses and Function of Human Regulatory and Conventional T-Cells
- (2013) Nahzli Dilek et al. PLoS One
- Zebularine inhibits tumorigenesis and stemness of colorectal cancer via p53-dependent endoplasmic reticulum stress
- (2013) Pei-Ming Yang et al. Scientific Reports
- Epigenetic induction of adaptive immune response in multiple myeloma: sequential azacitidine and lenalidomide generate cancer testis antigen-specific cellular immunity
- (2012) Amir A. Toor et al. BRITISH JOURNAL OF HAEMATOLOGY
- Epigenetic modulation of BRCA1 and BRCA2 gene expression by equol in breast cancer cell lines
- (2012) Rémy Bosviel et al. BRITISH JOURNAL OF NUTRITION
- Durable Cancer Regression Off-Treatment and Effective Reinduction Therapy with an Anti-PD-1 Antibody
- (2012) E. J. Lipson et al. CLINICAL CANCER RESEARCH
- Valproic acid cooperates with hydralazine to augment the susceptibility of human osteosarcoma cells to Fas- and NK cell-mediated cell death
- (2012) Koji Yamanegi INTERNATIONAL JOURNAL OF ONCOLOGY
- Sirtinol, a class III HDAC inhibitor, induces apoptotic and autophagic cell death in MCF-7 human breast cancer cells
- (2012) JING WANG et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Selective Histone Deacetylase 6 Inhibitors Bearing Substituted Urea Linkers Inhibit Melanoma Cell Growth
- (2012) Joel A. Bergman et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Salermide-Related Sirtuin Inhibitors: Binding Mode Studies and Antiproliferative Effects in Cancer Cells Including Cancer Stem Cells
- (2012) Dante Rotili et al. JOURNAL OF MEDICINAL CHEMISTRY
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- DNA Methylation-Independent Reversion of Gemcitabine Resistance by Hydralazine in Cervical Cancer Cells
- (2012) Myrna Candelaria et al. PLoS One
- Acetylated STAT3 is crucial for methylation of tumor-suppressor gene promoters and inhibition by resveratrol results in demethylation
- (2012) H. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Methylation of NEUROG1 in Serum Is a Sensitive Marker for the Detection of Early Colorectal Cancer
- (2011) Andreas Herbst et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- SAHA/TRAIL combination induces detachment and anoikis of MDA-MB231 and MCF-7 breast cancer cells
- (2011) M. Lauricella et al. BIOCHIMIE
- HDAC inhibitor M344 suppresses MCF-7 breast cancer cell proliferation
- (2011) Angie Yeung et al. BIOMEDICINE & PHARMACOTHERAPY
- Phase 1 study of epigenetic priming with decitabine prior to standard induction chemotherapy for patients with AML
- (2011) J. M. Scandura et al. BLOOD
- Immunotherapy augments the effect of 5-azacytidine on HPV16-associated tumours with different MHC class I-expression status
- (2011) J Šímová et al. BRITISH JOURNAL OF CANCER
- Decitabine and suberoylanilide hydroxamic acid (SAHA) inhibit growth of ovarian cancer cell lines and xenografts while inducing expression of imprinted tumor suppressor genes, apoptosis, G2/M arrest, and autophagy
- (2011) Min-Yu Chen et al. CANCER
- Combined Genetic Inactivation of β2-Microglobulin and CD58 Reveals Frequent Escape from Immune Recognition in Diffuse Large B Cell Lymphoma
- (2011) Madhavi Challa-Malladi et al. CANCER CELL
- Chidamide (CS055/HBI-8000): a new histone deacetylase inhibitor of the benzamide class with antitumor activity and the ability to enhance immune cell-mediated tumor cell cytotoxicity
- (2011) Zhi-Qiang Ning et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Expression and Immunotherapeutic Targeting of the SSX Family of Cancer-Testis Antigens in Prostate Cancer
- (2011) H. A. Smith et al. CANCER RESEARCH
- Inhibition of Histone Lysine Methylation Enhances Cancer-Testis Antigen Expression in Lung Cancer Cells: Implications for Adoptive Immunotherapy of Cancer
- (2011) M. Rao et al. CANCER RESEARCH
- Combination Therapy with Vidaza and Entinostat Suppresses Tumor Growth and Reprograms the Epigenome in an Orthotopic Lung Cancer Model
- (2011) Steven A. Belinsky et al. CANCER RESEARCH
- Rapid Synthesis of New DNMT Inhibitors Derivatives of Procainamide
- (2011) Ludovic Halby et al. CHEMBIOCHEM
- Nicotinamide, a SIRT1 inhibitor, inhibits differentiation and facilitates expansion of hematopoietic progenitor cells with enhanced bone marrow homing and engraftment
- (2011) Tony Peled et al. EXPERIMENTAL HEMATOLOGY
- Minimal Tolerance to a Tumor Antigen Encoded by a Cancer-Germline Gene
- (2011) I. J. Huijbers et al. JOURNAL OF IMMUNOLOGY
- Dendritic cell-targeted protein vaccines: a novel approach to induce T-cell immunity
- (2011) C. Trumpfheller et al. JOURNAL OF INTERNAL MEDICINE
- The novel inhibitor of histone deacetylase resminostat (RAS2410) inhibits proliferation and induces apoptosis in multiple myeloma (MM) cells
- (2010) Sonja Mandl-Weber et al. BRITISH JOURNAL OF HAEMATOLOGY
- Discovery of 2-(6-{[(6-Fluoroquinolin-2-yl)methyl]amino}bicyclo[3.1.0]hex-3-yl)-N-hydroxypyrimidine-5-carboxamide (CHR-3996), a Class I Selective Orally Active Histone Deacetylase Inhibitor
- (2010) David Moffat et al. JOURNAL OF MEDICINAL CHEMISTRY
- The DNA demethylating agent 5-aza-2′-deoxycytidine induces expression of NY-ESO-1 and other cancer/testis antigens in myeloid leukemia cells
- (2010) Maika Almstedt et al. LEUKEMIA RESEARCH
- SB939, a Novel Potent and Orally Active Histone Deacetylase Inhibitor with High Tumor Exposure and Efficacy in Mouse Models of Colorectal Cancer
- (2010) V. Novotny-Diermayr et al. MOLECULAR CANCER THERAPEUTICS
- Delivery of 5-Azacytidine to Human Cancer Cells by Elaidic Acid Esterification Increases Therapeutic Drug Efficacy
- (2010) B. Brueckner et al. MOLECULAR CANCER THERAPEUTICS
- Nanaomycin A Selectively Inhibits DNMT3B and Reactivates Silenced Tumor Suppressor Genes in Human Cancer Cells
- (2010) D. Kuck et al. MOLECULAR CANCER THERAPEUTICS
- S110, a 5-Aza-2'-Deoxycytidine-Containing Dinucleotide, Is an Effective DNA Methylation Inhibitor In vivo and Can Reduce Tumor Growth
- (2010) J. C. Chuang et al. MOLECULAR CANCER THERAPEUTICS
- Selective inhibition of histone deacetylase 6 (HDAC6) induces DNA damage and sensitizes transformed cells to anticancer agents
- (2010) M. Namdar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Expression of cancer/testis antigens in prostate cancer is associated with disease progression
- (2010) Takahito Suyama et al. PROSTATE
- 5-azacitidine restores and amplifies the bicalutamide response on preclinical models of androgen receptor expressing or deficient prostate tumors
- (2010) Giovanni Luca Gravina et al. PROSTATE
- Short Communication: Activation of Latent HIV Type 1 Gene Expression by Suberoylanilide Hydroxamic Acid (SAHA), an HDAC Inhibitor Approved for Use to Treat Cutaneous T Cell Lymphoma
- (2009) Leonard C. Edelstein et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- The histone deacetylase inhibitors LAQ824 and LBH589 do not require death receptor signaling or a functional apoptosome to mediate tumor cell death or therapeutic efficacy
- (2009) L. Ellis et al. BLOOD
- Effects of a novel DNA methyltransferase inhibitor zebularine on human breast cancer cells
- (2009) Madhavi Billam et al. BREAST CANCER RESEARCH AND TREATMENT
- Vorinostat in advanced prostate cancer patients progressing on prior chemotherapy (National Cancer Institute Trial 6862)
- (2009) Deborah Bradley et al. CANCER
- Genistein reverses hypermethylation and induces active histone modifications in tumor suppressor gene B-Cell translocation gene 3 in prostate cancer
- (2009) Shahana Majid et al. CANCER
- Relationship between HLA class I antigen processing machinery component expression and the clinicopathologic characteristics of bladder carcinomas
- (2009) Helen P. Cathro et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Association of HLA class I antigen abnormalities with disease progression and early recurrence in prostate cancer
- (2009) Barbara Seliger et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Development of the pan-DAC inhibitor panobinostat (LBH589): Successes and challenges
- (2009) Peter Atadja CANCER LETTERS
- Enhanced Antitumor Activity Induced by Adoptive T-Cell Transfer and Adjunctive Use of the Histone Deacetylase Inhibitor LAQ824
- (2009) D. D. Vo et al. CANCER RESEARCH
- JNJ-26481585, a Novel "Second-Generation" Oral Histone Deacetylase Inhibitor, Shows Broad-Spectrum Preclinical Antitumoral Activity
- (2009) J. Arts et al. CLINICAL CANCER RESEARCH
- High-Throughput Cell-Based Screening of 4910 Known Drugs and Drug-like Small Molecules Identifies Disulfiram as an Inhibitor of Prostate Cancer Cell Growth
- (2009) K. Iljin et al. CLINICAL CANCER RESEARCH
- Antigen processing and presentation: TAPping into ABC transporters
- (2009) Erik Procko et al. CURRENT OPINION IN IMMUNOLOGY
- The histone deacetylase inhibitor suberoylanilide hydroxamic acid sensitises human hepatocellular carcinoma cells to TRAIL-induced apoptosis by TRAIL-DISC activation
- (2009) Daniela Carlisi et al. EUROPEAN JOURNAL OF CANCER
- Reactivation of DNA viruses in association with histone deacetylase inhibitor therapy: a case series report
- (2009) D. Ritchie et al. HAEMATOLOGICA
- Gene Regulation and Chromatin Remodeling by IL-12 and Type I IFN in Programming for CD8 T Cell Effector Function and Memory
- (2009) P. Agarwal et al. JOURNAL OF IMMUNOLOGY
- Modulation of DNA Methylation by a Sesquiterpene Lactone Parthenolide
- (2009) Z. Liu et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Azacitidine favorably modulates PSA kinetics correlating with plasma DNA LINE-1 hypomethylation in men with chemonaïve castration-resistant prostate cancer
- (2009) Guru Sonpavde et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Curcumin is a potent DNA hypomethylation agent
- (2008) Zhongfa Liu et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery, In Vivo Activity, and Mechanism of Action of a Small-Molecule p53 Activator
- (2008) Sonia Lain et al. CANCER CELL
- Intertumor and Intratumor NY-ESO-1 Expression Heterogeneity Is Associated with Promoter-Specific and Global DNA Methylation Status in Ovarian Cancer
- (2008) A. Woloszynska-Read et al. CLINICAL CANCER RESEARCH
- Enhanced Functionality of CD4+CD25highFoxP3+ Regulatory T Cells in the Peripheral Blood of Patients with Prostate Cancer
- (2008) J. Yokokawa et al. CLINICAL CANCER RESEARCH
- Retracted: Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cells
- (2008) Nobuyuki Kikuno et al. INTERNATIONAL JOURNAL OF CANCER
- The DNA demethylating agent 5-aza-2′-deoxycytidine activates NY-ESO-1 antigenicity in orthotopic human glioma
- (2008) Atsushi Natsume et al. INTERNATIONAL JOURNAL OF CANCER
- A novel histone deacetylase 8 (HDAC8)-specific inhibitor PCI-34051 induces apoptosis in T-cell lymphomas
- (2008) S Balasubramanian et al. LEUKEMIA
- Specific Activity of Class II Histone Deacetylases in Human Breast Cancer Cells
- (2008) V. Duong et al. MOLECULAR CANCER RESEARCH
- MGCD0103, a novel isotype-selective histone deacetylase inhibitor, has broad spectrum antitumor activity in vitro and in vivo
- (2008) M. Fournel et al. MOLECULAR CANCER THERAPEUTICS
- DNA methylation landscapes: provocative insights from epigenomics
- (2008) Miho M. Suzuki et al. NATURE REVIEWS GENETICS
- Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect
- (2008) E Lara et al. ONCOGENE
- Genome-wide analysis of cancer/testis gene expression
- (2008) O. Hofmann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mammalian DNA Methyltransferases: A Structural Perspective
- (2008) Xiaodong Cheng et al. STRUCTURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now